Mayo Clinic: diagnostic, therapeutic advance for rare neurodegenerative disorder

(Mayo Clinic) Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3) ? a disease that has no cure. They also have clarified the role of a gene target associated with the disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news